Estimation of Drug Effectiveness by Modeling Three Time-Dependent Covariates: An Application to Data on Cardioprotective Medications in the Chronic Dialysis Population

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Statistics in Biopharmaceutical Research

• Publication date

  2014-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/19466315.2014.920275PMID 25343005PMCID PMC4203430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrial fibrillation and risk of stroke in dialysis patients.

  2013cited by this paper
• Flexible modeling of the cumulative effects of time‐dependent exposures on the hazard

  2011cited by this paper
• Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.

  2009cited by this paper
• Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

  2009cited by this paper
• Flexible modeling of the cumulative effects of time‐dependent exposures on the hazard

  2009cited by this paper
• The ABCs of cardioprotection in dialysis patients: a systematic review.

  2009cited by this paper
• Cardiovascular Protection With Antihypertensive Drugs in Dialysis Patients: Systematic Review and Meta-Analysis

  2009cited by this paper
• Tutorial in biostatistics: competing risks and multi‐state models

  2007cited by this paper
• Discontinuation of β-Blockers and the Risk of Myocardial Infarction in the Elderly

  2007cited by this paper
• Estimation and Prediction in a Multi‐State Model for Breast Cancer

  2006cited by this paper
• Comparison of two methodologies to analyze exposure to statins in an observational study on effectiveness.

  2004cited by this paper
• Survival Analysis: Techniques for Censored and Truncated Data

  2004cited by this paper
• The Statistical Analysis of Failure Time Data

  2003cited by this paper
• Analysis of Multivariate Survival Data

  2002cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Time-dependent covariates in the Cox proportional-hazards regression model.

  1999cited by this paper
• Assessing the effect of intensity when exposure varies over time.

  1997cited by this paper
• Survival Analysis Using SAS: A Practical Guide, Second Edition

  1995cited by this paper
• Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients.

  1993cited by this paper
• Survival Models and Data Analysis

  1982cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• University of Kansas School of Medicine.

  1956cited by this paper
• Regression Models and Life-Tables

  year unknowninfluential reference

• Switching to second line MS disease-modifying therapies is associated with decreased relapse rate

  2023influential citation
• Propensity Score Matching to Determine the Impact of Metformin on All-Cause Mortality in Older Veterans with Diabetes Mellitus

  2022cites this paper
• Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis

  2021cites this paper
• A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies

  2021cites this paper
• The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines

  2020cites this paper
• Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

  2019cites this paper
• Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients

  2016cites this paper
• Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study

  2016cites this paper